Immunic Inc. (IMUX)
NASDAQ: IMUX
· Real-Time Price · USD
0.90
-0.02 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
0.91
1.27%
After-hours: Aug 15, 2025, 07:58 PM EDT
Immunic Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -26.82M | -25.47M | -25.18M | -24.37M | -21.38M | -29.58M | -21.57M | -22.77M | -24M | -25.27M | -56.47M | -21.22M | -21.9M | -20.81M | -21.18M | -19.29M | -17.93M | -34.53M |
Depreciation & Amortization | 43K | 43K | 35K | 42K | 31K | 26K | 23K | 34K | 22K | 32K | 19K | 17K | 20K | 21K | 40K | 16K | 15K | 14K |
Stock-Based Compensation | 1.9M | 2.04M | 1.99M | 1.91M | 1.88M | 2.75M | 1.64M | 1.69M | 1.8M | 1.98M | 1.89M | 1.91M | 2.06M | 2.07M | 1.47M | 1.4M | 1.51M | 1.58M |
Other Working Capital | -973K | 3.64M | -2.2M | 3.66M | 1.74M | -5.78M | 4.3M | 5.09M | 2.59M | 2.25M | 6.31M | 3.26M | 926.00 | -1.76M | -5.57M | -273K | -5.7M | 2.09M |
Other Non-Cash Items | 55K | 53K | 121K | 56K | -487K | 6.83M | -273K | 47K | 149K | 516K | 33.51M | 2.11M | 3.13K | 149K | 1.13M | 1.3M | -600K | 8.63M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M |
Change in Working Capital | 214K | 1.56M | 71K | 1.56M | 2.92M | -3.99M | 6.07M | 3.69M | 2.05M | 3.23M | 5.96M | 3.58M | 2.1M | -2.11M | -5.13M | -1.02M | -11.99M | 8.86M |
Operating Cash Flow | -24.61M | -21.78M | -22.96M | -20.8M | -17.03M | -23.97M | -14.03M | -17.31M | -19.98M | -19.51M | -15.1M | -13.6M | -15.76M | -20.68M | -23.68M | -17.6M | -29M | -12.95M |
Capital Expenditures | -36K | -47K | -3K | -50K | -180K | -31K | -165K | -44K | -21K | -104K | 1K | -73K | -28K | -12K | -19K | -20K | -18K | -10K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 9.8M | n/a | n/a | n/a | -9.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -9.8M | n/a | 4.36M | 5.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.36K | 5.44K | -9.63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -36K | -47K | -3K | -50K | -180K | -31K | -165K | -44K | 4.34M | 5.33M | -9.63M | -73K | -28K | -12K | -19K | -20K | -18K | -10K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 74.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 123K | n/a | 77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 65.39M | n/a | 268K | n/a | n/a | n/a | 33K | n/a | 96K | 51K | 52K | n/a | 130K | 5K | 92K | n/a | n/a | n/a |
Financial Cash Flow | 65.52M | n/a | 77K | n/a | n/a | 74.46M | 604K | 282K | 96.00 | 51.00 | 56.04K | n/a | 10.08M | 29.64K | 821.00 | 42.02K | n/a | n/a |
Net Cash Flow | 41.01M | -21.36M | -23.4M | -20.63M | -17.61M | 50.64M | -13.02M | -17.61M | -15.47M | -13.98M | 33.97M | -15.31M | -7.63M | 8.85M | -23.58M | 23.27M | -27.66M | -12.61M |
Free Cash Flow | -24.64M | -21.82M | -22.97M | -20.85M | -17.21M | -24M | -14.19M | -17.36M | -20M | -19.62M | -15.1M | -13.67M | -15.79M | -20.69M | -23.7M | -17.62M | -29.02M | -12.96M |